In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Cg Oncology Inc (NASDAQ: CGON) closed at $26.07 in the last session, up 0.04% from day before closing price of $26.06. In other words, the price has increased by $0.04 from its previous closing price. On the day, 0.69 million shares were traded. CGON stock price reached its highest trading level at $26.438 during the session, while it also had its lowest trading level at $25.93.
Ratios:
We take a closer look at CGON’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 30.97 and its Current Ratio is at 30.97. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on May 02, 2025, initiated with a Overweight rating and assigned the stock a target price of $41.
On April 16, 2025, Scotiabank started tracking the stock assigning a Sector Perform rating and target price of $23.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 21 ’25 when POST LEONARD E sold 1,000 shares for $28.00 per share. The transaction valued at 28,000 led to the insider holds 0 shares of the business.
POST LEONARD E sold 1,000 shares of CGON for $30,760 on Apr 28 ’25. The Director now owns 0 shares after completing the transaction at $30.76 per share. On Mar 17 ’25, another insider, POST LEONARD E, who serves as the Director of the company, sold 1,000 shares for $28.00 each. As a result, the insider received 28,000 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 1987193472 and an Enterprise Value of 1299795840. For the stock, the TTM Price-to-Sale (P/S) ratio is 3010.90 while its Price-to-Book (P/B) ratio in mrq is 2.82. Its current Enterprise Value per Revenue stands at 1963.438 whereas that against EBITDA is -9.675.
Stock Price History:
The Beta on a monthly basis for CGON is 0.88, which has changed by -0.17421603 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, CGON has reached a high of $40.47, while it has fallen to a 52-week low of $14.80. The 50-Day Moving Average of the stock is 3.90%, while the 200-Day Moving Average is calculated to be -11.82%.
Shares Statistics:
According to the various share statistics, CGON traded on average about 1.38M shares per day over the past 3-months and 813310 shares per day over the past 10 days. A total of 76.22M shares are outstanding, with a floating share count of 44.88M. Insiders hold about 41.12% of the company’s shares, while institutions hold 68.21% stake in the company. Shares short for CGON as of 1749772800 were 11077034 with a Short Ratio of 8.01, compared to 1747267200 on 11556599. Therefore, it implies a Short% of Shares Outstanding of 11077034 and a Short% of Float of 15.39.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
